BMC Musculoskeletal Disorders · 2023 · 10 citations · 31 references
MedicineEndocrinologyBone MetabolismHuman NutritionNutritional EpidemiologyBone DisordersBone HealthBone Metabolism DisordersBone Quantity AssessmentFracture RiskMetabolic Bone DiseaseBone Fracture RiskBone Mineral DensityCross-sectional EpidemiologyFemur FracturesInsulin Resistance AssessmentMetabolic Bone Disease Assessment
Abstract Aim The purpose of this study was to investigate the association between the metabolic score for insulin resistance (METS-IR) and bone mineral density (BMD) in American non-diabetic adults. Methods We conducted a cross-sectional study with 1114 non-diabetic adults from the National Health and Nutrition Examination Survey cycle (2013–2014). The associations between METS-IR and BMD of total femur and spine were assessed by the multiple linear regression and verified the non-linear relationship with a smooth curve fit and threshold effect model. Furthermore, we evaluated the relationship between METS-IR, FRAX score, and history of bone fractures. Results We found that BMD of the total femur and spine increased by 0.005 g/cm 3 and 0.005 g/cm 3 , respectively, for a one-unit increase of METS-IR in all participants. This positive association was more pronounced among higher METS-IR participants, and there was a non-linear relationship, which was more significant when the MTTS-IR femur was < 41.62 or the METS-IR spine was < 41.39 (β femur = 0.008, β spine = 0.011, all P < 0.05). We also found that METS-IR was positively correlated with both FRAX scores in all female participants. However, METS-IR was positively correlated only with the 10-year hip fracture risk score in male participants with fractures. No significant association between METS-IR and a history of bone fractures. Conclusions In American non-diabetic adults, there is a correlation between elevated levels of METS-IR within the lower range and increased BMD as well as decreased risk of fractures, suggesting that METS-IR holds promise as a novel biomarker for guiding osteoporosis (OP) prevention. However, it is important to carefully balance the potential benefits and risks of METS-IR in OP.
31
Fernando Guerrero‐Romero, Luis E. Simental‐Mendía, Manuel González-Ortı́z et al. · The Journal of Clinical Endocrinology & Metabolism · 2010 · 2.3K citations · Full text
Medicine, Endocrinology, Diabetology +15
Omar Yaxmehen Bello‐Chavolla, Paloma Almeda‐Valdés, Donají Gómez‐Velasco et al. · European Journal of Endocrinology · 2018 · 622 citations